価格表

在庫・価格 : 2025年09月12日 20時54分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-OCT4, Rabbit-Poly
データシート
NB100-2379 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥96,000
(未発注)
追加

在庫・価格 : 2025年09月12日 20時54分 現在

Anti-OCT4, Rabbit-Poly

  • 商品コード:NB100-2379
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 McCulloh CJ et al. Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells. J Pediatr Surg 2017 Jun;52(6):999-1005
McCulloh CJ et al
2017/01/01
PubMed
2 Yang T et al. Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6. Stem Cell Res 2020 04;44:101777
Yang T et al
2020/01/01
PubMed
3 Lu H et al. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness. J Clin Invest 2020 09;130(9):4607-4623
Lu H et al
2020/01/01
PubMed
4 Gao Y et al. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human. Stem Cell Res 2020 03;43:101717
Gao Y et al
2020/01/01
PubMed
5 Li W et al. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight 2020 06;5(12)
Li W et al
2020/01/01
PubMed
6 Yang J et al. Construction of induced pluripotent stem cell line (ZZUi0017-A) from the fibroblast cells of a female patient with CACNA1A mutation by unintegrated reprogramming approach. Stem Cell Res 2020 10;48:101946
Yang J et al
2020/01/01
PubMed
7 B奪奪th M et al. MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer. Genes (Basel) 2021 05;12(5)
B奪奪th M et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    McCulloh CJ et al. Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells. J Pediatr Surg 2017 Jun;52(6):999-1005
    McCulloh CJ et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yang T et al. Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6. Stem Cell Res 2020 04;44:101777
    Yang T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Lu H et al. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness. J Clin Invest 2020 09;130(9):4607-4623
    Lu H et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gao Y et al. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human. Stem Cell Res 2020 03;43:101717
    Gao Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Li W et al. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight 2020 06;5(12)
    Li W et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Yang J et al. Construction of induced pluripotent stem cell line (ZZUi0017-A) from the fibroblast cells of a female patient with CACNA1A mutation by unintegrated reprogramming approach. Stem Cell Res 2020 10;48:101946
    Yang J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    B奪奪th M et al. MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer. Genes (Basel) 2021 05;12(5)
    B奪奪th M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed